2Yellon DM,Baxter GF, Garcia Dorado D, et al. Ischemic preconditioning:present position and future directions[J]. Cardiovasc Res. 1998,37:21~ 33
3Ikonomidis JS,Tumiati LC,Weisel RD, et al. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia[J]. Cardiovasc Res. 1994,28:1285~ 1291
4Ar tall MA, Zhao YZ, Hornberger L, et al. Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia[J]. J Mol Cell Cardiol. 1998,30:1019~ 1025
5Deutsch E, Berger M, Kussmaul WG, et al. Adatation to ischemia during percutaneous transluminal coronary angioplasty: clinical,hemodynamic, and metabolic features[J]. Circulation. 1990,82:2044~ 2051
6Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release[J]. Circulation. 1999,99:2085~ 2089
7Airaksinen KE, Huikuri HV.Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty[J]. J Am Coll Cardiol.1997,29:1035~ 1038
8Tomia F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitived K+ channel blocker[J]. Circulation. 1994,90:700~ 705
9Sato T, SasaKi N, Seharaseyon J, et al. Selective pharmacological agents implicate mitochondrial but not sarcolemmal K+ channels in ischemic cardioprotection[J].Circulation. 2000,101:2418~ 2423
10Yellon DM, Alkhulaifi AM, Pugsley WB.Preconditioning the human myocardium[J].Lancet. 1993,342:276~ 277
4Zhang ZW, Kaneda T, Ku K, et al.Ischemic preconditioning and nicorandil pretreatment improve donor heart preservation[J].Jpn Circ J.2001, 65(7):678~ 682
5Kevelaitis E, Oubenaissa A, Peynet J, et al.Preconditioning by mitochondrial ATP-sensitive potassium channel openers:an effective approach for improving the preservation of heart transplants[J].Circulation.1999, 100(II):345~ 350
6Hamada K, Yamazaki J,Nagao T.Shortening of action potential duration is not prerequite for cardiac protection by ischemic preconditioning or a KATP channel opener[J].J Mol Cell Cardiol.1998,30(7):1369~ 1379
7Sato T, Sasaki N, O'Rourke B, et al.Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels[J].J Am Coll Cardiol.2000, 35(2):514~ 518
8Sato T, Li Y,Saito T,et al.Minoxidil opens mitochondrial KATP channels and confers cardioprotection[J].British Journal of Pharmacology.2004, 141(2):360~ 366
9Laclau MN, Boudina S, Thambo JB, et al.Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase[J].J Mol Cell Cardiol.2001, 33(5):947
10Gumina RJ, Pucar D, Bast P, et al.Knockout of Kir6.2 negates ischemic preconditioning induced protection of myocardial energetics[J].Am J Physiol Heart Circ Physiol.2003, 284(6):2106~ 2113